The Society of Thoracic Surgeons (STS)-Interagency Registry for Mechanically Assisted
Circulatory Support (Intermacs) 2020 Annual Report reviews outcomes on 25,551 patients …

The Heart Failure Association of the European Society of Cardiology has published a
previous position paper and various guidelines over the past decade recognizing the value …

Heart failure is a complex entity, with high morbidity and mortality. The clinical course and
outcome are uncertain and difficult to predict. This document, instigated by the Heart Failure …

Purpose The aim of the study was to analyze early mortality after continuous-flow left
ventricular assist device (LVAD) implantation which remains high. Methods We analyzed …

Aims Left ventricular assist device therapy has become the cornerstone in the treatment of
end‐stage heart failure and is increasingly used as destination therapy next to bridge to …

As pump thrombosis is reduced in current‐generation ventricular assist devices (VAD),
adverse events such as bleeding or stroke remain at unacceptable rates. Thrombosis …

Background: When left ventricular assist device (LVAD) therapy no longer is able to achieve
patients' desired quality of life, withdrawal of LVAD therapy (WLVAD) may be requested …

Abstract Purpose of Review Although the utilization of mechanical circulatory support (MCS)
devices is increasing, ethical dilemmas regarding device deactivation and dying process …

OBJECTIVES To review the literature and summarize the evidence for left ventricular assist
device (LVAD) use in older adults (aged> 75 years), highlighting patient selection, day‐to …

La insuficiencia cardiaca es una entidad compleja, que conlleva elevada morbilidad y
mortalidad y cuyo curso y evolución son inciertos y difíciles de predecir. Este trabajo …